Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [654]

ASCO highlights: Bevacizumab for relapsed ovarian cancer

Prof Jonathan Ledermann - University College London Hospitals, London, UK

ASCO highlights: Bevacizumab for relapsed ovarian cancer ( Prof Jonathan Ledermann - University College London Hospitals, London, UK )

Uterine transplant in endometrial cancer

Richard Smith - Imperial College Healthcare NHS Trust, London, UK

Uterine transplant in endometrial cancer ( Richard Smith - Imperial College Healthcare NHS Trust, London, UK )

Unexpected role for Immuno-oncology in SCCOHT

Dr Douglas Levine - NYU Langone Medical Center, New York, USA

Unexpected role for Immuno-oncology in SCCOHT ( Dr Douglas Levine - NYU Langone Medical Center, New York, USA )

Surgical treatment of early cervical cancer – minimal access or open?

Prof Christina Fotopoulou - Imperial College London Healthcare Trust, London, UK

Surgical treatment of early cervical cancer – minimal access or open? ( Prof Christina Fotopoulou - Imperial College London Healthcare Trust, London, UK )

MyPathway study: a novel precision oncology multiple basket trial

Dr Mary S. Beattie - Genentech, USA

MyPathway study: a novel precision oncology multiple basket trial ( Dr Mary S. Beattie - Genentech, USA )

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

CDK6 a transcriptional regulator in AML

Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna...

CDK6 a transcriptional regulator in AML ( Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna, Austria )

Novel fusion proteins to target PD-L1 in HPV associated cancers

Dr James Gulley - Center for Cancer Research, Washington, USA

Novel fusion proteins to target PD-L1 in HPV associated cancers ( Dr James Gulley - Center for Cancer Research, Washington, USA )

Phase I study results of M7824 for patients with HPV associated cancers

Dr Julius Strauss - Center for Cancer Research, Washington, USA

Phase I study results of M7824 for patients with HPV associated cancers ( Dr Julius Strauss - Center for Cancer Research, Washington, USA )

ASCO 2018: Integrating genomic data throughout treatment for prostate cancer

Prof Kurt Miller and Prof Bertrand Tombal

ASCO 2018: Integrating genomic data throughout treatment for prostate cancer ( Prof Kurt Miller and Prof Bertrand Tombal )

Zoptarelin no better than doxarubicin for second-line advanced endometrial...

Dr David Miller - The University of Texas Southwestern Medical Center

Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer ( Dr David Miller - The University of Texas Southwestern Medical Center )

Editor’s Choice for May 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor’s Choice for May 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

More from ecancer